What's new in Interventional Cardiology

Fresh from his DOUBLE-CHOICE trial presentation at ESC Congress 2025 in Madrid, Mohamed Abdel-Wahab joins Yohei Ohno to discuss the key takeaways.

This two-by-two factorial randomised trial in patients undergoing TAVI compared a minimalist strategy using only local anesthesia with the standard of care, as well as two...

When a rota burr stalls in a calcified artery, quick thinking and the right technique are critical. Discover a proven method to recover the burr safely and avoid surgery.

Stay updated with the latest in interventional cardiology at #ESCCongress 2025!

A stalled rota burr is every operator’s nightmare — but being prepared can make all the difference. In this case, an 80-year-old patient with severe calcification in the proximal and mid LAD faces exactly that complication.

What’s your first step to safely retrieve the burr and complete...

Welcome to Turning Point, a new podcast series brought to you by EuroIntervention — as part of our 20th anniversary celebration. 

Incomplete surgical LAA closure: how would you proceed?
Despite prior closure with an Atriclip during CABG, transoesophageal echocardiography reveals a persistent LAA gap in a high-risk patient with recurrent bleeding.
Explore the clinical details, imaging, and treatment dilemmas—then share your management approach!

Managing ACS in a high-bleeding-risk patient is always a delicate balance. In this case, an 83-year-old with NSTEMI, advanced CKD, and a recent intracranial hemorrhage presented with a complex mid-to-distal LAD lesion. What would be your strategy?

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...